LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more

Garry Wills by Garry Wills
August 4, 2025
in Business Finance
Stocks making the biggest moves after hours: Palantir, Hims & Hers Health, Vertex Pharmaceuticals and more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter

[ad_1]

Check out the companies making headlines in extended trading. Palantir — The defense technology stock advanced 4% after second-quarter earnings exceeded Wall Street’s expectations. Palantir said it reported adjusted earnings of 16 cents per share on $1.00 billion in revenue, while analysts polled by LSEG anticipated 14 cents per share and $940 million, respectively. Vertex Pharmaceuticals — The biotech stock sank 14% after second-quarter earnings topped estimates. Vertex posted adjusted earnings of $4.52 per share on revenue of $2.96 billion, while analysts surveyed by LSEG had penciled in $4.26 per share and $2.91 billion. Hims & Hers Health – Shares tumbled 12% after the telehealth company issued disappointing guidance. Hims sees third-quarter adjusted earnings before interest, taxes, depreciation and amortization ranging from $60 million to $70 million, while StreetAccount consensus estimates called for $77 million. Second-quarter results were mixed, with revenue missing expectations, while adjusted earnings narrowly beat. Syndax Pharmaceuticals – The biopharma stock slipped 3% after Syndax guided for a third-quarter research and development expense of between $95 million to $100 million, while analysts polled by FactSet had expected $65.8 million. However, the company posted second-quarter revenue that exceeded expectations, as well as a narrower-than-expected loss per share. Dorman Products — The vehicle part supplier popped 7% after hiking its full-year earnings guidance to between $8.60 and $8.90 per share, excluding items, from a range of $7.55 to $7.85 a share. Dorman also issued better-than-expected top- and bottom-line results for the second quarter, per FactSet. V2X – Shares rose more than 2% after the aerospace and defense company’s second-quarter results beat Wall Street’s expectations. V2X posted adjusted earnings of 33 cents per share, while analysts polled by FactSet had penciled in 97 cents per share. The company’s revenue of $1.08 billion also beat the consensus estimate of $1.05 billion. Additionally, it raised its full-year earnings forecast. MercadoLibre — Shares dropped 4% after the Latin American e-commerce platform reported second-quarter earnings that missed expectations. MercadoLibre posted earnings of $10.31 per share, below the $11.93 per share estimated by analysts polled by FactSet. On the other hand, expected revenue of $6.79 billion topped the $6.67 billion consensus estimate. — CNBC’s Darla Mercado, Sean Conlon, Lisa Kailai Han and Sarah Min contributed reporting

[ad_2]

Source link

You might also like

China exports growth in March misses estimates, imports surge most in over four years

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

Share30Tweet19
Previous Post

From $129 a month: 5 of the best EV lease deals in August

Next Post

GENIUS Act scrutinized for stablecoin yield ban as TradFi tokenization gains steam

Garry Wills

Garry Wills

Recommended For You

China exports growth in March misses estimates, imports surge most in over four years
Business Finance

China exports growth in March misses estimates, imports surge most in over four years

April 14, 2026
Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more
Business Finance

Stocks making the biggest moves premarket: Goldman Sachs, Revolution Medicines, Fastenal & more

April 13, 2026
Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects
Business Finance

Goldman Sachs is set to report first-quarter earnings — here’s what Wall Street expects

April 13, 2026
Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions
Business Finance

Morgan Stanley predicts these beaten-down Chinese stocks can rebound on easing Middle East tensions

April 12, 2026
Next Post
GENIUS Act scrutinized for stablecoin yield ban as TradFi tokenization gains steam

GENIUS Act scrutinized for stablecoin yield ban as TradFi tokenization gains steam

Related News

IoTeX launches AI Foundry as a decentralized alternative to ‘closed AI’

IoTeX launches AI Foundry as a decentralized alternative to ‘closed AI’

September 30, 2025
Kremlin warns it will be an ‘act of war’ if NATO shoots down Russian jets – London Business News | London Wallet

Kremlin warns it will be an ‘act of war’ if NATO shoots down Russian jets – London Business News | London Wallet

September 26, 2025
Bank of America says New York Community Bancorp plunge is ‘not an indicator of a wider problem’

Bank of America says New York Community Bancorp plunge is ‘not an indicator of a wider problem’

February 1, 2024

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?